And also, you know, these cost very little to manufacture. That's just the bottom line. The cost of goods is very low. And so if you can still eke out a profit in Germany, selling it at 50% of the price, you can gain in the US that's still profit to be had. So companies are going to try to sell as much as they can to as many countries as they can based on what those markets are willing to pay. (05:49–05:58)
CLAIM
Asserts that drug manufacturing costs are low, allowing profit even at reduced prices.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
